Occult hepatitis B virus infection of donor and recipient origin after liver transplantation despite nucleoside analogue prophylaxis

Liver Transplantation

Volumn 16, Issue 11, 2010, Pages 1314-1323

  Cheung, Cindy Ka Yee ^a   Lo, Chung Mau ^a   Man, Kwan ^a   Lau, George Ka Kit ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; COVALENTLY CLOSED CIRCULAR DNA; DNA; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NUCLEOSIDE ANALOG; TACROLIMUS; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA SEQUENCE; DONOR; DRUG TREATMENT FAILURE; FEMALE; GRAFT INFECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; INFECTION PREVENTION; LIVER BIOPSY; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; PHYLOGENY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECIPIENT;

ANTIVIRAL AGENTS; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNOGLOBULINS; IMMUNOHISTOCHEMISTRY; LAMIVUDINE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NUCLEOSIDES; TISSUE DONORS;

EID: 78349285207     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22169     Document Type: Article

References (27)

1. Lo CM, Fan ST, Liu CL, Lai CL, Wong J., Prophylaxis and treatment of recurrent hepatitis B after liver transplantation. Transplantation 2003; 75: S41 - S44.
2. Gane EJ, Angus PW, Strasser S, Crawford DH, Ring J, Jeffrey GP, et al. Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation. Gastroenterology 2007; 132: 931 - 937.
3. Beckebaum S, Sotiropoulos GC, Gerken G, Cicinnati VR., Hepatitis B and liver transplantation: 2008 update. Rev Med Virol 2009; 19: 7 - 29.
4. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65 - 73.
5. Roche B, Feray C, Gigou M, Roque-Afonso AM, Arulnaden JL, Delvart V, et al. HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis. Hepatology 2003; 38: 86 - 95.
6. Hussain M, Soldevila-Pico C, Emre S, Luketic V, Lok AS., Presence of intrahepatic (total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation. Liver Transpl 2007; 13: 1137 - 1144.
7. Summers J, Jilbert AR, Yang W, Aldrich CE, Saputelli J, Litwin S, et al. Hepatocyte turnover during resolution of a transient hepadnaviral infection. Proc Natl Acad Sci U S A 2003; 100: 11652 - 11659.
8. Sung JJ, Wong ML, Bowden S, Liew CT, Hui AY, Wong VW, et al. Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy. Gastroenterology 2005; 128: 1890 - 1897.
9. Zhu Y, Yamamoto T, Cullen J, Saputelli J, Aldrich CE, Miller DS, et al. Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J Virol 2001; 75: 311 - 322.
10. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Villari D, de Franchis R, et al. Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. Hepatology 2000; 31: 507 - 512.
11. Dodson SF, Issa S, Araya V, Gayowski T, Pinna A, Eghtesad B, et al. Infectivity of hepatic allografts with antibodies to hepatitis B virus. Transplantation 1997; 64: 1582 - 1584.
12. Dickson RC, Everhart JE, Lake JR, Wei Y, Seaberg EC, Wiesner RH, et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology 1997; 113: 1668 - 1674.
13. Prieto M, Gomez MD, Berenguer M, Cordoba J, Rayon JM, Pastor M, et al. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transpl 2001; 7: 51 - 58.
14. Chen YS, Wang CC, de Villa VH, Wang SH, Cheng YF, Huang TL, et al. Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors. Clin Transplant 2002; 16: 405 - 409.
15. Gow PJ, Mutimer DJ., De novo hepatitis B infection acquired during liver transplantation. QJM 2001; 94: 271 - 275.
16. Kobak AC, Karasu Z, Kilic M, Ozacar T, Tekin F, Gunsar F, et al. Living donor liver transplantation from hepatitis B core antibody positive donors. Transplant Proc 2007; 39: 1488 - 1490.
17. Minami M, Poussin K, Brechot C, Paterlini P., A novel PCR technique using Alu-specific primers to identify unknown flanking sequences from the human genome. Genomics 1995; 29: 403 - 408.
18. Loeb KR, Jerome KR, Goddard J, Huang M, Cent A, Corey L., High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system. Hepatology 2000; 32: 626 - 629.
19. Bowden S, Jackson K, Littlejohn M, Locarnini S., Quantification of HBV covalently closed circular DNA from liver tissue by real-time PCR. Methods Mol Med 2004; 95: 41 - 50.
20. Lu L, Zhang HY, Yueng YH, Cheung KF, Luk JM, Wang FS, et al. Intracellular levels of hepatitis B virus DNA and pregenomic RNA in peripheral blood mononuclear cells of chronically infected patients. J Viral Hepat 2009; 16: 104 - 112.
21. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696 - 699.
22. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG., The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997; 25: 4876 - 4882.
23. Lok AS, Lai CL, Wu PC, Wong VC, Yeoh EK, Lin HJ., Hepatitis B virus infection in Chinese families in Hong Kong. Am J Epidemiol 1987; 126: 492 - 499.
24. Werle-Lapostolle B, Bowden S, Locarnini S, Wursthorn K, Petersen J, Lau G, et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 2004; 126: 1750 - 1758.
25. Chaudhuri V, Tayal R, Nayak B, Acharya SK, Panda SK., Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterology 2004; 127: 1356 - 1371.
26. Pollicino T, Raffa G, Costantino L, Lisa A, Campello C, Squadrito G, et al. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology 2007; 45: 277 - 285.
27. Vivekanandan P, Kannangai R, Ray SC, Thomas DL, Torbenson M., Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples. Clin Infect Dis 2008; 46: 1227 - 1236.